Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer.

IF 3.8 Q2 GASTROENTEROLOGY & HEPATOLOGY Translational gastroenterology and hepatology Pub Date : 2024-08-14 eCollection Date: 2024-01-01 DOI:10.21037/tgh-24-44

Erfan Taherifard, Anwaar Saeed

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

可切除胃癌和胃食管交界癌的新辅助 PD-1/PD-L1 抑制剂加化疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

IF 4 2区医学Cancer MedicinePub Date : 2022-11-07 DOI: 10.1002/cam4.5414

Jia-lin Tang, Bo Zhang, Jian-ping Xu, Ling Qi, Dao Xin, Lin Wang, Bing-zhi Wang, Yan-tao Tian, Yong Li, Jing Huang

Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.

IF 4.7 3区医学Frontiers in OncologyPub Date : 2023-01-01 DOI: 10.3389/fonc.2023.1103320

Zhen Yuan, Hao Cui, Shuyuan Wang, Wenquan Liang, Bo Cao, Liqiang Song, Guibin Liu, Jun Huang, Lin Chen, Bo Wei

PD-L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy

IF 2.5 3区医学Journal of Surgical OncologyPub Date : 2022-06-11 DOI: 10.1002/jso.26929

Héber S. C. Ribeiro MD, PhD, Jacqueline N. Menezes MD, Wilson L. da Costa Jr. MD, PhD, Victor Hugo F. de Jesus MD, Alessandro L. Diniz MD, André L. Godoy MD, Igor Correia de Farias MD, Silvio M. Torres MD, Tatiane Neotti MD, Celso A. L. Mello MD, PhD, Maria Dirlei F. S. Begnami MD, PhD, Emmanuel Dias-Neto PhD, Rachel P. Riechelmann MD, PhD, Felipe José Fernandez Coimbra MD

来源期刊

Translational gastroenterology and hepatology

自引率

0.00%

发文量